Hmdb loader
Survey
You are using an unsupported browser. Please upgrade your browser to a newer version to get the best experience on Human Metabolome Database.
Record Information
Version5.0
StatusExpected but not Quantified
Creation Date2012-09-06 15:00:19 UTC
Update Date2021-09-14 15:20:33 UTC
HMDB IDHMDB0013880
Secondary Accession Numbers
  • HMDB13880
Metabolite Identification
Common NameS-6-Hydroxywarfarin
DescriptionS-6-Hydroxywarfarin belongs to the class of organic compounds known as homoisoflavones. These are homoisoflavonoids with a structure based on the chromone system. Chromone is a bicyclic compound consisting of a 1-benzopyran, which bears a ketone group at the 4-position. S-6-Hydroxywarfarin is only found in individuals that have used or taken Warfarin. S-6-Hydroxywarfarin is an extremely weak basic (essentially neutral) compound (based on its pKa).
Structure
Data?1582753150
SynonymsNot Available
Chemical FormulaC19H16O5
Average Molecular Weight324.3273
Monoisotopic Molecular Weight324.099773622
IUPAC Name2,6-dihydroxy-3-[(1S)-3-oxo-1-phenylbutyl]-4H-chromen-4-one
Traditional Name2,6-dihydroxy-3-[(1S)-3-oxo-1-phenylbutyl]chromen-4-one
CAS Registry NumberNot Available
SMILES
[H][C@](CC(C)=O)(C1=CC=CC=C1)C1=C(O)OC2=CC=C(O)C=C2C1=O
InChI Identifier
InChI=1S/C19H16O5/c1-11(20)9-14(12-5-3-2-4-6-12)17-18(22)15-10-13(21)7-8-16(15)24-19(17)23/h2-8,10,14,21,23H,9H2,1H3/t14-/m0/s1
InChI KeyJFCOGWFGPAUYNK-AWEZNQCLSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as homoisoflavones. These are homoisoflavonoids with a structure based on the chromone system. Chromone is a bicyclic compound consisting of a 1-benzopyran, which bears a ketone group at the 4-position.
KingdomOrganic compounds
Super ClassPhenylpropanoids and polyketides
ClassHomoisoflavonoids
Sub ClassHomoisoflavones
Direct ParentHomoisoflavones
Alternative Parents
Substituents
  • Homoisoflavone
  • Chromone
  • Coumarin
  • Benzopyran
  • 1-benzopyran
  • 1-hydroxy-2-unsubstituted benzenoid
  • Pyranone
  • Monocyclic benzene moiety
  • Pyran
  • Benzenoid
  • Heteroaromatic compound
  • Vinylogous acid
  • Ketone
  • Oxacycle
  • Organoheterocyclic compound
  • Organooxygen compound
  • Hydrocarbon derivative
  • Organic oxide
  • Carbonyl group
  • Organic oxygen compound
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
Water Solubility0.034 g/LALOGPS
logP2.72ALOGPS
logP3.22ChemAxon
logS-4ALOGPS
pKa (Strongest Acidic)7.75ChemAxon
pKa (Strongest Basic)-5.5ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count5ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area83.83 ŲChemAxon
Rotatable Bond Count4ChemAxon
Refractivity97.97 m³·mol⁻¹ChemAxon
Polarizability32.91 ųChemAxon
Number of Rings3ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+172.82330932474
DeepCCS[M-H]-170.46530932474
DeepCCS[M-2H]-204.3230932474
DeepCCS[M+Na]+179.54830932474
AllCCS[M+H]+175.432859911
AllCCS[M+H-H2O]+172.032859911
AllCCS[M+NH4]+178.632859911
AllCCS[M+Na]+179.532859911
AllCCS[M-H]-178.732859911
AllCCS[M+Na-2H]-178.232859911
AllCCS[M+HCOO]-177.832859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
S-6-Hydroxywarfarin[H][C@](CC(C)=O)(C1=CC=CC=C1)C1=C(O)OC2=CC=C(O)C=C2C1=O4159.4Standard polar33892256
S-6-Hydroxywarfarin[H][C@](CC(C)=O)(C1=CC=CC=C1)C1=C(O)OC2=CC=C(O)C=C2C1=O2789.2Standard non polar33892256
S-6-Hydroxywarfarin[H][C@](CC(C)=O)(C1=CC=CC=C1)C1=C(O)OC2=CC=C(O)C=C2C1=O3022.4Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
S-6-Hydroxywarfarin,1TMS,isomer #1CC(=O)C[C@@H](C1=CC=CC=C1)C1=C(O[Si](C)(C)C)OC2=CC=C(O)C=C2C1=O2827.8Semi standard non polar33892256
S-6-Hydroxywarfarin,1TMS,isomer #2CC(=O)C[C@@H](C1=CC=CC=C1)C1=C(O)OC2=CC=C(O[Si](C)(C)C)C=C2C1=O2763.5Semi standard non polar33892256
S-6-Hydroxywarfarin,1TMS,isomer #3CC(=C[C@@H](C1=CC=CC=C1)C1=C(O)OC2=CC=C(O)C=C2C1=O)O[Si](C)(C)C2924.9Semi standard non polar33892256
S-6-Hydroxywarfarin,1TMS,isomer #4C=C(C[C@@H](C1=CC=CC=C1)C1=C(O)OC2=CC=C(O)C=C2C1=O)O[Si](C)(C)C2861.4Semi standard non polar33892256
S-6-Hydroxywarfarin,2TMS,isomer #1CC(=O)C[C@@H](C1=CC=CC=C1)C1=C(O[Si](C)(C)C)OC2=CC=C(O[Si](C)(C)C)C=C2C1=O2837.5Semi standard non polar33892256
S-6-Hydroxywarfarin,2TMS,isomer #2CC(=C[C@@H](C1=CC=CC=C1)C1=C(O[Si](C)(C)C)OC2=CC=C(O)C=C2C1=O)O[Si](C)(C)C2902.7Semi standard non polar33892256
S-6-Hydroxywarfarin,2TMS,isomer #3C=C(C[C@@H](C1=CC=CC=C1)C1=C(O[Si](C)(C)C)OC2=CC=C(O)C=C2C1=O)O[Si](C)(C)C2847.3Semi standard non polar33892256
S-6-Hydroxywarfarin,2TMS,isomer #4CC(=C[C@@H](C1=CC=CC=C1)C1=C(O)OC2=CC=C(O[Si](C)(C)C)C=C2C1=O)O[Si](C)(C)C2877.2Semi standard non polar33892256
S-6-Hydroxywarfarin,2TMS,isomer #5C=C(C[C@@H](C1=CC=CC=C1)C1=C(O)OC2=CC=C(O[Si](C)(C)C)C=C2C1=O)O[Si](C)(C)C2843.5Semi standard non polar33892256
S-6-Hydroxywarfarin,3TMS,isomer #1CC(=C[C@@H](C1=CC=CC=C1)C1=C(O[Si](C)(C)C)OC2=CC=C(O[Si](C)(C)C)C=C2C1=O)O[Si](C)(C)C2933.5Semi standard non polar33892256
S-6-Hydroxywarfarin,3TMS,isomer #1CC(=C[C@@H](C1=CC=CC=C1)C1=C(O[Si](C)(C)C)OC2=CC=C(O[Si](C)(C)C)C=C2C1=O)O[Si](C)(C)C3004.0Standard non polar33892256
S-6-Hydroxywarfarin,3TMS,isomer #1CC(=C[C@@H](C1=CC=CC=C1)C1=C(O[Si](C)(C)C)OC2=CC=C(O[Si](C)(C)C)C=C2C1=O)O[Si](C)(C)C3255.0Standard polar33892256
S-6-Hydroxywarfarin,3TMS,isomer #2C=C(C[C@@H](C1=CC=CC=C1)C1=C(O[Si](C)(C)C)OC2=CC=C(O[Si](C)(C)C)C=C2C1=O)O[Si](C)(C)C2873.2Semi standard non polar33892256
S-6-Hydroxywarfarin,3TMS,isomer #2C=C(C[C@@H](C1=CC=CC=C1)C1=C(O[Si](C)(C)C)OC2=CC=C(O[Si](C)(C)C)C=C2C1=O)O[Si](C)(C)C2834.2Standard non polar33892256
S-6-Hydroxywarfarin,3TMS,isomer #2C=C(C[C@@H](C1=CC=CC=C1)C1=C(O[Si](C)(C)C)OC2=CC=C(O[Si](C)(C)C)C=C2C1=O)O[Si](C)(C)C3254.2Standard polar33892256
S-6-Hydroxywarfarin,1TBDMS,isomer #1CC(=O)C[C@@H](C1=CC=CC=C1)C1=C(O[Si](C)(C)C(C)(C)C)OC2=CC=C(O)C=C2C1=O3066.5Semi standard non polar33892256
S-6-Hydroxywarfarin,1TBDMS,isomer #2CC(=O)C[C@@H](C1=CC=CC=C1)C1=C(O)OC2=CC=C(O[Si](C)(C)C(C)(C)C)C=C2C1=O3029.3Semi standard non polar33892256
S-6-Hydroxywarfarin,1TBDMS,isomer #3CC(=C[C@@H](C1=CC=CC=C1)C1=C(O)OC2=CC=C(O)C=C2C1=O)O[Si](C)(C)C(C)(C)C3190.3Semi standard non polar33892256
S-6-Hydroxywarfarin,1TBDMS,isomer #4C=C(C[C@@H](C1=CC=CC=C1)C1=C(O)OC2=CC=C(O)C=C2C1=O)O[Si](C)(C)C(C)(C)C3135.3Semi standard non polar33892256
S-6-Hydroxywarfarin,2TBDMS,isomer #1CC(=O)C[C@@H](C1=CC=CC=C1)C1=C(O[Si](C)(C)C(C)(C)C)OC2=CC=C(O[Si](C)(C)C(C)(C)C)C=C2C1=O3259.5Semi standard non polar33892256
S-6-Hydroxywarfarin,2TBDMS,isomer #2CC(=C[C@@H](C1=CC=CC=C1)C1=C(O[Si](C)(C)C(C)(C)C)OC2=CC=C(O)C=C2C1=O)O[Si](C)(C)C(C)(C)C3398.4Semi standard non polar33892256
S-6-Hydroxywarfarin,2TBDMS,isomer #3C=C(C[C@@H](C1=CC=CC=C1)C1=C(O[Si](C)(C)C(C)(C)C)OC2=CC=C(O)C=C2C1=O)O[Si](C)(C)C(C)(C)C3295.1Semi standard non polar33892256
S-6-Hydroxywarfarin,2TBDMS,isomer #4CC(=C[C@@H](C1=CC=CC=C1)C1=C(O)OC2=CC=C(O[Si](C)(C)C(C)(C)C)C=C2C1=O)O[Si](C)(C)C(C)(C)C3409.9Semi standard non polar33892256
S-6-Hydroxywarfarin,2TBDMS,isomer #5C=C(C[C@@H](C1=CC=CC=C1)C1=C(O)OC2=CC=C(O[Si](C)(C)C(C)(C)C)C=C2C1=O)O[Si](C)(C)C(C)(C)C3340.7Semi standard non polar33892256
S-6-Hydroxywarfarin,3TBDMS,isomer #1CC(=C[C@@H](C1=CC=CC=C1)C1=C(O[Si](C)(C)C(C)(C)C)OC2=CC=C(O[Si](C)(C)C(C)(C)C)C=C2C1=O)O[Si](C)(C)C(C)(C)C3570.3Semi standard non polar33892256
S-6-Hydroxywarfarin,3TBDMS,isomer #1CC(=C[C@@H](C1=CC=CC=C1)C1=C(O[Si](C)(C)C(C)(C)C)OC2=CC=C(O[Si](C)(C)C(C)(C)C)C=C2C1=O)O[Si](C)(C)C(C)(C)C3582.9Standard non polar33892256
S-6-Hydroxywarfarin,3TBDMS,isomer #1CC(=C[C@@H](C1=CC=CC=C1)C1=C(O[Si](C)(C)C(C)(C)C)OC2=CC=C(O[Si](C)(C)C(C)(C)C)C=C2C1=O)O[Si](C)(C)C(C)(C)C3516.1Standard polar33892256
S-6-Hydroxywarfarin,3TBDMS,isomer #2C=C(C[C@@H](C1=CC=CC=C1)C1=C(O[Si](C)(C)C(C)(C)C)OC2=CC=C(O[Si](C)(C)C(C)(C)C)C=C2C1=O)O[Si](C)(C)C(C)(C)C3471.3Semi standard non polar33892256
S-6-Hydroxywarfarin,3TBDMS,isomer #2C=C(C[C@@H](C1=CC=CC=C1)C1=C(O[Si](C)(C)C(C)(C)C)OC2=CC=C(O[Si](C)(C)C(C)(C)C)C=C2C1=O)O[Si](C)(C)C(C)(C)C3391.7Standard non polar33892256
S-6-Hydroxywarfarin,3TBDMS,isomer #2C=C(C[C@@H](C1=CC=CC=C1)C1=C(O[Si](C)(C)C(C)(C)C)OC2=CC=C(O[Si](C)(C)C(C)(C)C)C=C2C1=O)O[Si](C)(C)C(C)(C)C3528.7Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - S-6-Hydroxywarfarin GC-MS (Non-derivatized) - 70eV, Positivesplash10-0006-8692000000-71790d12b9852db68acf2017-09-01Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - S-6-Hydroxywarfarin GC-MS (2 TMS) - 70eV, Positivesplash10-0f6x-9414500000-37afb3d80a8174036fa62017-10-06Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - S-6-Hydroxywarfarin GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - S-6-Hydroxywarfarin 10V, Positive-QTOFsplash10-056r-0029000000-0c31e2ee084e343027132016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - S-6-Hydroxywarfarin 20V, Positive-QTOFsplash10-0a6r-0279000000-30bc24ec970dd82f45442016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - S-6-Hydroxywarfarin 40V, Positive-QTOFsplash10-00kr-1490000000-be0e0c09b5fe04ee4d7b2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - S-6-Hydroxywarfarin 10V, Negative-QTOFsplash10-00fr-1169000000-2e0685d4491c7644c05c2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - S-6-Hydroxywarfarin 20V, Negative-QTOFsplash10-004i-3596000000-6a9206b094dbf74223c52016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - S-6-Hydroxywarfarin 40V, Negative-QTOFsplash10-0bvl-8690000000-f3a39c08726274a625c52016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - S-6-Hydroxywarfarin 10V, Negative-QTOFsplash10-00di-0309000000-60b14d5b0a019f92e5c72021-09-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - S-6-Hydroxywarfarin 20V, Negative-QTOFsplash10-004i-2934000000-16bac68e7604aff5db432021-09-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - S-6-Hydroxywarfarin 40V, Negative-QTOFsplash10-0pbc-8961000000-27c3cb3b22dbc449e50e2021-09-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - S-6-Hydroxywarfarin 10V, Positive-QTOFsplash10-004i-0829000000-8246a6fbedba02caddc12021-09-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - S-6-Hydroxywarfarin 20V, Positive-QTOFsplash10-004i-0951000000-94515aed645edace7aad2021-09-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - S-6-Hydroxywarfarin 40V, Positive-QTOFsplash10-000i-1941000000-30290d01602decce74d32021-09-25Wishart LabView Spectrum
Biological Properties
Cellular Locations
  • Extracellular
Biospecimen Locations
  • Blood
  • Urine
Tissue Locations
  • Kidney
  • Liver
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableTaking drug identified by DrugBank entry details
UrineExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableTaking drug identified by DrugBank entry details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider IDNot Available
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound13427218
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General ReferencesNot Available

Enzymes

General function:
Involved in transferase activity, transferring hexosyl groups
Specific function:
UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. This isoform glucuronidates bilirubin IX-alpha to form both the IX-alpha-C8 and IX-alpha-C12 monoconjugates and diconjugate. Is also able to catalyze the glucuronidation of 17beta-estradiol, 17alpha-ethinylestradiol, 1-hydroxypyrene, 4-methylumbelliferone, 1-naphthol, paranitrophenol, scopoletin, and umbelliferone.
Gene Name:
UGT1A1
Uniprot ID:
P22309
Molecular weight:
59590.91
Reactions
S-6-Hydroxywarfarin → 3,4,5-trihydroxy-6-({2-hydroxy-4-oxo-3-[(1S)-3-oxo-1-phenylbutyl]-4H-chromen-6-yl}oxy)oxane-2-carboxylic aciddetails
S-6-Hydroxywarfarin → 3,4,5-trihydroxy-6-({6-hydroxy-4-oxo-3-[(1S)-3-oxo-1-phenylbutyl]-4H-chromen-2-yl}oxy)oxane-2-carboxylic aciddetails
General function:
Involved in monooxygenase activity
Specific function:
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It performs a variety of oxidation reactions (e.g. caffeine 8-oxidation, omeprazole sulphoxidation, midazolam 1'-hydroxylation and midazolam 4-hydroxylation) of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. Acts as a 1,8-cineole 2-exo-monooxygenase. The enzyme also hydroxylates etoposide.
Gene Name:
CYP3A4
Uniprot ID:
P08684
Molecular weight:
57255.585
References
  1. Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. [PubMed:19515014 ]
  2. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
General function:
Involved in monooxygenase activity
Specific function:
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. This enzyme contributes to the wide pharmacokinetics variability of the metabolism of drugs such as S-warfarin, diclofenac, phenytoin, tolbutamide and losartan.
Gene Name:
CYP2C9
Uniprot ID:
P11712
Molecular weight:
55627.365
References
  1. Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. [PubMed:19515014 ]
  2. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
General function:
Involved in monooxygenase activity
Specific function:
Responsible for the metabolism of a number of therapeutic agents such as the anticonvulsant drug S-mephenytoin, omeprazole, proguanil, certain barbiturates, diazepam, propranolol, citalopram and imipramine.
Gene Name:
CYP2C19
Uniprot ID:
P33261
Molecular weight:
55944.565
References
  1. Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. [PubMed:19515014 ]
  2. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
General function:
Involved in monooxygenase activity
Specific function:
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics.
Gene Name:
CYP2C18
Uniprot ID:
P33260
Molecular weight:
55710.075
References
  1. Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. [PubMed:19515014 ]
  2. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
General function:
Involved in monooxygenase activity
Specific function:
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics.
Gene Name:
CYP1A1
Uniprot ID:
P04798
Molecular weight:
58164.815
References
  1. Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. [PubMed:19515014 ]
General function:
Involved in monooxygenase activity
Specific function:
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. Most active in catalyzing 2-hydroxylation. Caffeine is metabolized primarily by cytochrome CYP1A2 in the liver through an initial N3-demethylation. Also acts in the metabolism of aflatoxin B1 and acetaminophen. Participates in the bioactivation of carcinogenic aromatic and heterocyclic amines. Catalizes the N-hydroxylation of heterocyclic amines and the O-deethylation of phenacetin.
Gene Name:
CYP1A2
Uniprot ID:
P05177
Molecular weight:
58406.915
References
  1. Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. [PubMed:19515014 ]
  2. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
General function:
Involved in monooxygenase activity
Specific function:
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. In the epoxidation of arachidonic acid it generates only 14,15- and 11,12-cis-epoxyeicosatrienoic acids. It is the principal enzyme responsible for the metabolism the anti-cancer drug paclitaxel (taxol).
Gene Name:
CYP2C8
Uniprot ID:
P10632
Molecular weight:
55824.275
References
  1. Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. [PubMed:19515014 ]
  2. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
General function:
Involved in vitamin-K-epoxide reductase (warfarin-sensi
Specific function:
Involved in vitamin K metabolism. Catalytic subunit of the vitamin K epoxide reductase (VKOR) complex which reduces inactive vitamin K 2,3-epoxide to active vitamin K.
Gene Name:
VKORC1
Uniprot ID:
Q9BQB6
Molecular weight:
18234.3
References
  1. Gebauer M: Synthesis and structure-activity relationships of novel warfarin derivatives. Bioorg Med Chem. 2007 Mar 15;15(6):2414-20. Epub 2007 Jan 17. [PubMed:17275317 ]
  2. Zhu Y, Shennan M, Reynolds KK, Johnson NA, Herrnberger MR, Valdes R Jr, Linder MW: Estimation of warfarin maintenance dose based on VKORC1 (-1639 G>A) and CYP2C9 genotypes. Clin Chem. 2007 Jul;53(7):1199-205. Epub 2007 May 17. [PubMed:17510308 ]
  3. Yin T, Miyata T: Warfarin dose and the pharmacogenomics of CYP2C9 and VKORC1 - rationale and perspectives. Thromb Res. 2007;120(1):1-10. Epub 2006 Dec 11. [PubMed:17161452 ]
  4. Osman A, Enstrom C, Lindahl TL: Plasma S/R ratio of warfarin co-varies with VKORC1 haplotype. Blood Coagul Fibrinolysis. 2007 Apr;18(3):293-6. [PubMed:17413769 ]
  5. Limdi NA, McGwin G, Goldstein JA, Beasley TM, Arnett DK, Adler BK, Baird MF, Acton RT: Influence of CYP2C9 and VKORC1 1173C/T genotype on the risk of hemorrhagic complications in African-American and European-American patients on warfarin. Clin Pharmacol Ther. 2008 Feb;83(2):312-21. Epub 2007 Jul 25. [PubMed:17653141 ]
  6. Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. [PubMed:11752352 ]